Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 697 to 702 of 702 entries
Sorted by: Best Match Show Resources per page
Discriminative detection of laser-accelerated multi-MeV carbon ions utilizing solid state nuclear track detectors.

Scientific reports

Hihara T, Kanasaki M, Asai T, Kusumoto T, Kodaira S, Kiriyama H, Oda K, Yamauchi T, Woon WY, Kuramitsu Y, Fukuda Y.
PMID: 34381072
Sci Rep. 2021 Aug 11;11(1):16283. doi: 10.1038/s41598-021-92300-1.

A new diagnosis method for the discriminative detection of laser-accelerated multi-MeV carbon ions from background oxygen ions utilizing solid-state nuclear track detectors (SSNTDs) is proposed. The idea is to combine two kinds of SSNTDs having different track registration sensitivities:...

Cite
Hihara T, Kanasaki M, Asai T, et al. Discriminative detection of laser-accelerated multi-MeV carbon ions utilizing solid state nuclear track detectors. Sci Rep. 2021;11(1):16283doi: 10.1038/s41598-021-92300-1.
Hihara, T., Kanasaki, M., Asai, T., Kusumoto, T., Kodaira, S., Kiriyama, H., Oda, K., Yamauchi, T., Woon, W. Y., Kuramitsu, Y., & Fukuda, Y. (2021). Discriminative detection of laser-accelerated multi-MeV carbon ions utilizing solid state nuclear track detectors. Scientific reports, 11(1), 16283. https://doi.org/10.1038/s41598-021-92300-1
Hihara, Takamasa, et al. "Discriminative detection of laser-accelerated multi-MeV carbon ions utilizing solid state nuclear track detectors." Scientific reports vol. 11,1 (2021): 16283. doi: https://doi.org/10.1038/s41598-021-92300-1
Hihara T, Kanasaki M, Asai T, Kusumoto T, Kodaira S, Kiriyama H, Oda K, Yamauchi T, Woon WY, Kuramitsu Y, Fukuda Y. Discriminative detection of laser-accelerated multi-MeV carbon ions utilizing solid state nuclear track detectors. Sci Rep. 2021 Aug 11;11(1):16283. doi: 10.1038/s41598-021-92300-1. PMID: 34381072; PMCID: PMC8358032.
Copy Download .nbib Format: NLM
Association of Blood Pressure Classification Using the 2017 American College of Cardiology/American Heart Association Blood Pressure Guideline With Risk of Heart Failure and Atrial Fibrillation.

Circulation

Kaneko H, Yano Y, Itoh H, Morita K, Kiriyama H, Kamon T, Fujiu K, Michihata N, Jo T, Takeda N, Morita H, Node K, Carey RM, Lima JAC, Oparil S, Yasunaga H, Komuro I.
PMID: 33886370
Circulation. 2021 Jun 08;143(23):2244-2253. doi: 10.1161/CIRCULATIONAHA.120.052624. Epub 2021 Apr 22.

BACKGROUND: Heart failure (HF) and atrial fibrillation (AF) are growing in prevalence worldwide. Few studies have assessed to what extent stage 1 hypertension in the 2017 American College of Cardiology/American Heart Association blood pressure (BP) guidelines is associated with...

Cite
Kaneko H, Yano Y, Itoh H, et al. Association of Blood Pressure Classification Using the 2017 American College of Cardiology/American Heart Association Blood Pressure Guideline With Risk of Heart Failure and Atrial Fibrillation. Circulation. 2021;143(23):2244-2253doi: 10.1161/CIRCULATIONAHA.120.052624.
Kaneko, H., Yano, Y., Itoh, H., Morita, K., Kiriyama, H., Kamon, T., Fujiu, K., Michihata, N., Jo, T., Takeda, N., Morita, H., Node, K., Carey, R. M., Lima, J. A. C., Oparil, S., Yasunaga, H., & Komuro, I. (2021). Association of Blood Pressure Classification Using the 2017 American College of Cardiology/American Heart Association Blood Pressure Guideline With Risk of Heart Failure and Atrial Fibrillation. Circulation, 143(23), 2244-2253. https://doi.org/10.1161/CIRCULATIONAHA.120.052624
Kaneko, Hidehiro, et al. "Association of Blood Pressure Classification Using the 2017 American College of Cardiology/American Heart Association Blood Pressure Guideline With Risk of Heart Failure and Atrial Fibrillation." Circulation vol. 143,23 (2021): 2244-2253. doi: https://doi.org/10.1161/CIRCULATIONAHA.120.052624
Kaneko H, Yano Y, Itoh H, Morita K, Kiriyama H, Kamon T, Fujiu K, Michihata N, Jo T, Takeda N, Morita H, Node K, Carey RM, Lima JAC, Oparil S, Yasunaga H, Komuro I. Association of Blood Pressure Classification Using the 2017 American College of Cardiology/American Heart Association Blood Pressure Guideline With Risk of Heart Failure and Atrial Fibrillation. Circulation. 2021 Jun 08;143(23):2244-2253. doi: 10.1161/CIRCULATIONAHA.120.052624. Epub 2021 Apr 22. PMID: 33886370.
Copy Download .nbib Format: NLM
OCT-Based Management of Nilotinib-Associated CAD in a Patient With Chronic Myeloid Leukemia.

JACC. CardioOncology

Kiriyama H, Ishida J, Kadowaki H, Iwasa T, Kiyosue A, Kodera S, Ando J, Akazawa H, Komuro I.
PMID: 34396200
JACC CardioOncol. 2019 Dec 17;1(2):318-321. doi: 10.1016/j.jaccao.2019.09.006. eCollection 2019 Dec.

No abstract available.

Cite
Kiriyama H, Ishida J, Kadowaki H, et al. OCT-Based Management of Nilotinib-Associated CAD in a Patient With Chronic Myeloid Leukemia. JACC CardioOncol. 2019;1(2):318-321doi: 10.1016/j.jaccao.2019.09.006.
Kiriyama, H., Ishida, J., Kadowaki, H., Iwasa, T., Kiyosue, A., Kodera, S., Ando, J., Akazawa, H., & Komuro, I. (2019). OCT-Based Management of Nilotinib-Associated CAD in a Patient With Chronic Myeloid Leukemia. JACC. CardioOncology, 1(2), 318-321. https://doi.org/10.1016/j.jaccao.2019.09.006
Kiriyama, Hiroyuki, et al. "OCT-Based Management of Nilotinib-Associated CAD in a Patient With Chronic Myeloid Leukemia." JACC. CardioOncology vol. 1,2 (2019): 318-321. doi: https://doi.org/10.1016/j.jaccao.2019.09.006
Kiriyama H, Ishida J, Kadowaki H, Iwasa T, Kiyosue A, Kodera S, Ando J, Akazawa H, Komuro I. OCT-Based Management of Nilotinib-Associated CAD in a Patient With Chronic Myeloid Leukemia. JACC CardioOncol. 2019 Dec 17;1(2):318-321. doi: 10.1016/j.jaccao.2019.09.006. eCollection 2019 Dec. PMID: 34396200; PMCID: PMC8352223.
Copy Download .nbib Format: NLM
Simple Scoring System for Predicting TACE Unsuitable among Intermediate-Stage Hepatocellular Carcinoma Patients in the Multiple Systemic Treatment Era.

Oncology

Hiraoka A, Kumada T, Kariyama K, Toyoda H, Yasuda S, Tsuji K, Hatanaka T, Kakizaki S, Naganuma A, Ishikawa T, Tada T, Takaguchi K, Itobayashi E, Shimada N, Shibata H, Tanaka T, Tsutsui A, Nagano T, Imai M, Nakamura S, Nouso K.
PMID: 34844247
Oncology. 2021 Nov 29;1-9. doi: 10.1159/000520292. Epub 2021 Nov 29.

BACKGROUND/AIM: With the development of systemic treatment methods for unresectable hepatocellular carcinoma (uHCC), the concept of unsuitable for transcatheter arterial chemoembolization (TACE) has become important. This study aimed to establish a simple predictive scoring system for determining TACE unsuitable...

Cite
Hiraoka A, Kumada T, Kariyama K, et al. Simple Scoring System for Predicting TACE Unsuitable among Intermediate-Stage Hepatocellular Carcinoma Patients in the Multiple Systemic Treatment Era. Oncology. 2021;1-9doi: 10.1159/000520292.
Hiraoka, A., Kumada, T., Kariyama, K., Toyoda, H., Yasuda, S., Tsuji, K., Hatanaka, T., Kakizaki, S., Naganuma, A., Ishikawa, T., Tada, T., Takaguchi, K., Itobayashi, E., Shimada, N., Shibata, H., Tanaka, T., Tsutsui, A., Nagano, T., Imai, M., Nakamura, S., & Nouso, K. (2021). Simple Scoring System for Predicting TACE Unsuitable among Intermediate-Stage Hepatocellular Carcinoma Patients in the Multiple Systemic Treatment Era. Oncology, 1-9. https://doi.org/10.1159/000520292
Hiraoka, Atsushi, et al. "Simple Scoring System for Predicting TACE Unsuitable among Intermediate-Stage Hepatocellular Carcinoma Patients in the Multiple Systemic Treatment Era." Oncology vol. (2021): 1-9. doi: https://doi.org/10.1159/000520292
Hiraoka A, Kumada T, Kariyama K, Toyoda H, Yasuda S, Tsuji K, Hatanaka T, Kakizaki S, Naganuma A, Ishikawa T, Tada T, Takaguchi K, Itobayashi E, Shimada N, Shibata H, Tanaka T, Tsutsui A, Nagano T, Imai M, Nakamura S, Nouso K. Simple Scoring System for Predicting TACE Unsuitable among Intermediate-Stage Hepatocellular Carcinoma Patients in the Multiple Systemic Treatment Era. Oncology. 2021 Nov 29;1-9. doi: 10.1159/000520292. Epub 2021 Nov 29. PMID: 34844247.
Copy Download .nbib Format: NLM
Construction of 1,2,3-Benzodiazaborole by Electrophilic Borylation of Azobenzene and Nucleophilic Dialkylative Cyclization.

Organic letters

Shigeno M, Imamatsu M, Kai Y, Kiriyama M, Ishida S, Nozawa-Kumada K, Kondo Y.
PMID: 34613748
Org Lett. 2021 Oct 15;23(20):8023-8027. doi: 10.1021/acs.orglett.1c03033. Epub 2021 Oct 06.

1,2,3-Benzodiazaboroles can be conveniently prepared from azobenzenes by a two-step protocol involving electrophilic

Cite
Shigeno M, Imamatsu M, Kai Y, et al. Construction of 1,2,3-Benzodiazaborole by Electrophilic Borylation of Azobenzene and Nucleophilic Dialkylative Cyclization. Org Lett. 2021;23(20):8023-8027doi: 10.1021/acs.orglett.1c03033.
Shigeno, M., Imamatsu, M., Kai, Y., Kiriyama, M., Ishida, S., Nozawa-Kumada, K., & Kondo, Y. (2021). Construction of 1,2,3-Benzodiazaborole by Electrophilic Borylation of Azobenzene and Nucleophilic Dialkylative Cyclization. Organic letters, 23(20), 8023-8027. https://doi.org/10.1021/acs.orglett.1c03033
Shigeno, Masanori, et al. "Construction of 1,2,3-Benzodiazaborole by Electrophilic Borylation of Azobenzene and Nucleophilic Dialkylative Cyclization." Organic letters vol. 23,20 (2021): 8023-8027. doi: https://doi.org/10.1021/acs.orglett.1c03033
Shigeno M, Imamatsu M, Kai Y, Kiriyama M, Ishida S, Nozawa-Kumada K, Kondo Y. Construction of 1,2,3-Benzodiazaborole by Electrophilic Borylation of Azobenzene and Nucleophilic Dialkylative Cyclization. Org Lett. 2021 Oct 15;23(20):8023-8027. doi: 10.1021/acs.orglett.1c03033. Epub 2021 Oct 06. PMID: 34613748.
Copy Download .nbib Format: NLM
Fasting Plasma Glucose and Incident Colorectal Cancer: Analysis of a Nationwide Epidemiological Database.

The Journal of clinical endocrinology and metabolism

Itoh H, Kaneko H, Okada A, Yano Y, Morita K, Seki H, Kiriyama H, Kamon T, Fujiu K, Matsuoka S, Nakamura S, Michihata N, Jo T, Takeda N, Morita H, Nishiyama A, Node K, Yasunaga H, Komuro I.
PMID: 34378781
J Clin Endocrinol Metab. 2021 Jun 25; doi: 10.1210/clinem/dgab466. Epub 2021 Jun 25.

CONTEXT: Although diabetes mellitus (DM) was reported to be associated with incident colorectal cancer (CRC), the detailed association between fasting plasma glucose (FPG) and incident CRC has not been fully understood.OBJECTIVE: We assessed whether hyperglycemia is associated with a...

Cite
Itoh H, Kaneko H, Okada A, et al. Fasting Plasma Glucose and Incident Colorectal Cancer: Analysis of a Nationwide Epidemiological Database. J Clin Endocrinol Metab. 2021;doi: 10.1210/clinem/dgab466.
Itoh, H., Kaneko, H., Okada, A., Yano, Y., Morita, K., Seki, H., Kiriyama, H., Kamon, T., Fujiu, K., Matsuoka, S., Nakamura, S., Michihata, N., Jo, T., Takeda, N., Morita, H., Nishiyama, A., Node, K., Yasunaga, H., & Komuro, I. (2021). Fasting Plasma Glucose and Incident Colorectal Cancer: Analysis of a Nationwide Epidemiological Database. The Journal of clinical endocrinology and metabolism, . https://doi.org/10.1210/clinem/dgab466
Itoh, Hidetaka, et al. "Fasting Plasma Glucose and Incident Colorectal Cancer: Analysis of a Nationwide Epidemiological Database." The Journal of clinical endocrinology and metabolism vol. (2021). doi: https://doi.org/10.1210/clinem/dgab466
Itoh H, Kaneko H, Okada A, Yano Y, Morita K, Seki H, Kiriyama H, Kamon T, Fujiu K, Matsuoka S, Nakamura S, Michihata N, Jo T, Takeda N, Morita H, Nishiyama A, Node K, Yasunaga H, Komuro I. Fasting Plasma Glucose and Incident Colorectal Cancer: Analysis of a Nationwide Epidemiological Database. J Clin Endocrinol Metab. 2021 Jun 25; doi: 10.1210/clinem/dgab466. Epub 2021 Jun 25. PMID: 34378781.
Copy Download .nbib Format: NLM
Showing 697 to 702 of 702 entries